A new Canadian study finds that antibiotics can slow the progress of multiple sclerosis (MS). The study, published in the New England Journal of Medicine, used minocycline to treat early relapsing remitting MS. The annual cost of treatment with antibiotics ($600) is substantially... Read More »




























